143 related articles for article (PubMed ID: 32570315)
21. In vitro endocrine disruption potential of organophosphate flame retardants via human nuclear receptors.
Kojima H; Takeuchi S; Itoh T; Iida M; Kobayashi S; Yoshida T
Toxicology; 2013 Dec; 314(1):76-83. PubMed ID: 24051214
[TBL] [Abstract][Full Text] [Related]
22. Identification of dicyclohexyl phthalate as a glucocorticoid receptor antagonist by molecular docking and multiple in vitro methods.
Leng Y; Sun Y; Huang W; Lv C; Cui J; Li T; Wang Y
Mol Biol Rep; 2021 Apr; 48(4):3145-3154. PubMed ID: 33881729
[TBL] [Abstract][Full Text] [Related]
23. In silico methods in the discovery of endocrine disrupting chemicals.
Vuorinen A; Odermatt A; Schuster D
J Steroid Biochem Mol Biol; 2013 Sep; 137():18-26. PubMed ID: 23688835
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in silico investigations of endocrine disruption induced by metabolites of plasticizers through glucocorticoid receptor.
Leng Y; Ren L; Niu S; Zhang T; Zhang J
Food Chem Toxicol; 2021 Sep; 155():112413. PubMed ID: 34273429
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoid and mineralocorticoid receptors and corticosteroid homeostasis are potential targets for endocrine-disrupting chemicals.
Zhang J; Yang Y; Liu W; Schlenk D; Liu J
Environ Int; 2019 Dec; 133(Pt A):105133. PubMed ID: 31520960
[TBL] [Abstract][Full Text] [Related]
26. Biological analysis of endocrine-disrupting compounds in Tunisian sewage treatment plants.
Mnif W; Dagnino S; Escande A; Pillon A; Fenet H; Gomez E; Casellas C; Duchesne MJ; Hernandez-Raquet G; Cavaillès V; Balaguer P; Bartegi A
Arch Environ Contam Toxicol; 2010 Jul; 59(1):1-12. PubMed ID: 20033144
[TBL] [Abstract][Full Text] [Related]
27. Alternative methods in vitro for screening of endocrine disruptors.
Dvořáková M; Kejlová K; Bendová H; Rucki M; Kohout P; Vavrouš A; Jírová D
Neuro Endocrinol Lett; 2016 Dec; 37(Suppl1):123-131. PubMed ID: 28263540
[TBL] [Abstract][Full Text] [Related]
28. Endocrine Disruptors Acting on Estrogen and Androgen Pathways Cause Reproductive Disorders through Multiple Mechanisms: A Review.
Amir S; Shah STA; Mamoulakis C; Docea AO; Kalantzi OI; Zachariou A; Calina D; Carvalho F; Sofikitis N; Makrigiannakis A; Tsatsakis A
Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33557243
[TBL] [Abstract][Full Text] [Related]
29. Profiling of bisphenol A and eight its analogues on transcriptional activity via human nuclear receptors.
Kojima H; Takeuchi S; Sanoh S; Okuda K; Kitamura S; Uramaru N; Sugihara K; Yoshinari K
Toxicology; 2019 Feb; 413():48-55. PubMed ID: 30582956
[TBL] [Abstract][Full Text] [Related]
30. Rapid and reagent-free bioassay using autobioluminescent yeasts to detect agonistic and antagonistic activities of bisphenols against rat androgen receptor and progesterone receptor.
Huang Y; Zhang W; Zhang C; Cui N; Xiao Z; Wang R; Su X
J Steroid Biochem Mol Biol; 2022 Sep; 222():106151. PubMed ID: 35787454
[TBL] [Abstract][Full Text] [Related]
31. Assessment of endocrine-disrupting effects of emerging polyhalogenated carbazoles (PHCZs): In vitro, in silico, and in vivo evidence.
Yue S; Zhang T; Shen Q; Song Q; Ji C; Chen Y; Mao M; Kong Y; Chen D; Liu J; Sun Z; Zhao M
Environ Int; 2020 Jul; 140():105729. PubMed ID: 32344252
[TBL] [Abstract][Full Text] [Related]
32. Optical probes to identify the glucocorticoid receptor ligands in living cells.
Awais M; Sato M; Umezawa Y
Steroids; 2007 Dec; 72(14):949-54. PubMed ID: 17897691
[TBL] [Abstract][Full Text] [Related]
33. An Integrated Approach of Bioassays and Non-Target Screening for the Assessment of Endocrine-Disrupting Activities in Tap Water and Identification of Novel Endocrine-Disrupting Chemicals.
Liu S; Liu J
Toxics; 2024 Mar; 12(4):. PubMed ID: 38668470
[TBL] [Abstract][Full Text] [Related]
34. In vitro profiling of endocrine disrupting effects of phenols.
Li J; Ma M; Wang Z
Toxicol In Vitro; 2010 Feb; 24(1):201-7. PubMed ID: 19765641
[TBL] [Abstract][Full Text] [Related]
35. Effects of central nervous system drugs on androgen, estrogen α, glucocorticoid, and thyroid receptors.
Kenda M; Zore T; Sollner Dolenc M
Chem Biol Interact; 2022 Aug; 363():110030. PubMed ID: 35760085
[TBL] [Abstract][Full Text] [Related]
36. An analytical survey of benzotriazole UV stabilizers in plastic products and their endocrine-disrupting potential via human estrogen and androgen receptors.
Sakuragi Y; Takada H; Sato H; Kubota A; Terasaki M; Takeuchi S; Ikeda-Araki A; Watanabe Y; Kitamura S; Kojima H
Sci Total Environ; 2021 Dec; 800():149374. PubMed ID: 34388645
[TBL] [Abstract][Full Text] [Related]
37. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells.
Mueller SO; Simon S; Chae K; Metzler M; Korach KS
Toxicol Sci; 2004 Jul; 80(1):14-25. PubMed ID: 15084758
[TBL] [Abstract][Full Text] [Related]
38. Receptor-binding affinities of bisphenol A and its next-generation analogs for human nuclear receptors.
Liu X; Sakai H; Nishigori M; Suyama K; Nawaji T; Ikeda S; Nishigouchi M; Okada H; Matsushima A; Nose T; Shimohigashi M; Shimohigashi Y
Toxicol Appl Pharmacol; 2019 Aug; 377():114610. PubMed ID: 31195007
[TBL] [Abstract][Full Text] [Related]
39. Computational prediction models for assessing endocrine disrupting potential of chemicals.
Sakkiah S; Guo W; Pan B; Kusko R; Tong W; Hong H
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2018; 36(4):192-218. PubMed ID: 30633647
[TBL] [Abstract][Full Text] [Related]
40. Endocrine-disrupting potentials of equine estrogens equilin, equilenin, and their metabolites, in the medaka Oryzias latipes: in silico and DNA microarray studies.
Uchida M; Ishibashi H; Yamamoto R; Koyanagi A; Kusano T; Tominaga N; Ishibashi Y; Arizono K
J Appl Toxicol; 2015 Sep; 35(9):1040-8. PubMed ID: 25611945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
